Abstract: According to one embodiment, a wireless communication device, includes a receiver configured to receive a first field, receive at least one of a plurality of second fields having been multiplexed and transmitted, and decode the one of the second fields to obtain a frame in a case where first information identifying the wireless communication device is not set in the first field, and a controller configured to suppress access to a wireless medium during a period indicated by a value set in the frame.

Abstract: A compound of formula (1): Z1-?a-?b-?c-?d-?e-Z2 ??(1), wherein ?, ?, ?, ?, and ? are respectively units of formulas (1?), (1?), (1?), (1?), and (1?): and the structure of the unit ? is different from the structure of the unit ?, the structure of the unit ? is different from the structure of the unit ?, the structure of the unit ? is different from the structure of the unit ?, and the structure of the unit ? is different from the structure of the unit ?.

Abstract: The object of the invention is to provide a novel reservoir assembly for providing a cardioplegic solution and a method for manufacturing the same.

Abstract: A foodstuff of a tablet or capsule, includes: an extract of a plant of genus Salacia; and at least one of calcium carbonate and silicon dioxide in an amount of 1% by mass or more based on the total mass of the tablet or capsule, wherein 50% inhibition concentration (IC50 value) of sucrase is 10 ?g/ml or more and 300 ?g/ml or less.

Abstract: A method for separating and purifying RNA including the steps of passing a sample solution containing a nucleic acid, a washing solution and a recovering solution through a nucleic acid-adsorbing porous membrane to adsorb nucleic, adsorbing, washing and recovering, in which the nucleic acid adsorbing porous membrane is a porous membrane capable of adsorbing a nucleic acid by interaction involving substantially no ionic bond, and the sample solution is obtained by a process, comprising the steps of (I) injecting a test sample containing at least one of blood and leukocyte, and further containing an anticoagulant to a container, (II) adding a hemolytic agent to the container to obtain a leukocyte pellet, (III) adding a nucleic acid-solubilizing reagent to the leukocyte pallet to obtain a mixture solution and (IV) adding a water-soluble organic solvent to the mixture solution to obtain the sample solution containing the nucleic acid.

Abstract: A foodstuff of a tablet or capsule, includes: an extract of a plant of genus Salacia; and at least one of calcium carbonate and silicon dioxide in an amount of 1% by mass or more based on the total mass of the tablet or capsule, wherein 50% inhibition concentration (IC50 value) of sucrase is 10 ?g/ml or more and 300 ?g/ml or less.

Abstract: An affinity carrier not of a particle aggregation type but in a gel state having a bicontinuous structure composed of pores having an average diameter of micrometer size arranged continuously in a three-dimensional network structure and a skeletal phase abundant in organic matters, comprising at least one compound having at least two functionalities as a crosslinking agent of a vinyl monomer compound, a methacrylate compound or an acrylate compound; and a copolymer of at least one monofunctional hydrophilic monomer as a ligand-carrying monomer and at least one monofunctional thinning monomer as a thinning agent for arbitrarily controlling a hydrophilic/hydrophobic environment in which a ligand carried by said ligand-carrying monomer is put, wherein a volume ratio of said crosslinking agent to “said copolymer of the monofunctional hydrophilic monomer and the mono functional thinning monomer” in said affinity carrier is 100 to 10:0 to 90.

Abstract: A method for separating and purifying RNA including the steps of passing a sample solution containing a nucleic acid, a washing solution and a recovering solution through a nucleic acid-adsorbing porous membrane to adsorb nucleic acid, adsorbing, washing and recovering, in which the nucleic acid adsorbing porous membrane is a porous membrane capable of adsorbing a nucleic acid by interaction involving substantially no ionic bond, and the sample solution is obtained by a process, comprising the steps of (I) injecting a test sample containing at least one of blood and leukocyte, and further containing an anticoagulant to a container, (II) adding a hemolytic agent to the container to obtain a leukocyte pallet, (III) adding a nucleic acid-solubilizing reagent to the leukocyte pallet to obtain a mixture solution and (IV) adding a water-soluble organic solvent to the mixture solution to obtain the sample solution containing the nucleic acid.

Abstract: A mobile communication terminal having a digital camera and which is comprised of a first section and a second section. There are four structural states realized by folding up of the mobile communication terminal and rotation of a display section with respect to a base section of the second section. In each of the four structural states, the mobile communication terminal automatically allocates operations modes of camera mode and non-camera mode. Also, the mobile communication terminal can automatically change the operating mode as required.

Abstract: A mobile communication terminal having a digital camera and which is comprised of a first section and a second section. There are four structural states realized by folding up of the mobile communication terminal and rotation of a display section with respect to a base section of the second section. In each of the four structural states, the mobile communication terminal automatically allocates operations modes of camera mode and non-camera mode. Also, the mobile communication terminal can automatically change the operating mode as required.